Clover Wolf Capital - Limited Partnership

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return12%19%11%0%0%
Purchase Success Rate4 of 63 of 61 of 60 of 60 of 6
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Pluristem Therapeutics, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 3.12M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--